Medical Crossfire®: Overcoming Obstacles and Improving Patient Access to PCSK9 Inhibitors: A Team-Based Approach
This activity is supported by an educational grant from Amgen Inc.
CME-accredited Medical Crossfire®
Harold E. Bays, MD, FTOS, FACE, FNLA
Louisville Metabolic and Atherosclerosis Research Center
Kevin C. Maki, PhD
Midwest Biomedical Research Center for Metabolic and Cardiovascular Health
Glen Ellyn, Illinois
Joyce L. Ross, MSN, CRNP, CLS, FNLA, FPCNA
Independent Consult and Educator
Immediate Past President, National Lipid Association
Past President Preventive Cardiovascular Nurses Association
University of Pennsylvania
West Chester, Pennsylvania
Catherine Davis Ahmed, MBA
Vice President, Policy and Outreach
This activity will serve as a call to action and will bring together a cardiologist, a specialty NP, a patient advocate, and a managed care representative to address the limited access to PCSK9 inhibitors. This multidisciplinary panel will unite to discuss this issue and raise awareness in hopes of changing policies to allow more widespread access to PCSK9 inhibitors.
Upon completion of this educational activity, participants will be able to:
Identify high-risk individuals, including those with residual ASCVD risk such as familial hypercholesterolemia, diabetic dyslipidemia, and/or statin intolerance who would benefit for PCSK9 therapy
Summarize the evidence on the risks and benefits of new and emerging hypercholesterolemia therapies to guide treatment and management decisions for patients with hypercholesterolemia who are not at goal
Develop effective strategies for patient-centered hypercholesterolemia management including patient education, medication risks/benefits, adherence, and lifestyle modifications
Explain how to implement a team-based approach to improve patient access and adherence to PCSK9 inhibitors
Target Audience: The educational design of this activity addresses the needs of lipidologists, cardiologists, and specialty allied health professionals with an interest in the diagnosis and management of hypercholesterolemia. Activity Type: Medical Crossfire® Release Date: 12/28/17 Expiration Date: 12/28/18 Estimated Time to Complete Activity: 1 hour Fee: Free
This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC. AMA PRA Category 1 Credit™ is provided by Global Education Group.
Credit Designation Statement(s):
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians’ Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Physicians’ Education Resource®, LLC. Global Education Group is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1.0 contact hour(s) which includes 0.0 hour(s) of pharmacology.
Activity ID #2471E
This activity was planned in accordance with AANP CE Standards and Policies.
Disclosure of Unlabeled Use:
This activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to the diagnostic, treatment, and management options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Instructions Default instructions: (add/delete as needed) To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.
Harold E. Bays, MD, FTOS, FACE, FNLA – In the past 12 months, Dr. Harold Bays’ research site has received research grants from Amarin, Amgen, Alere, Allergan, Arisaph, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Catabasis, Dr. Reddy, Eisai, Elcelyx, Eli Lilly, Esperion, Ferrer/Chiltern, Gemphire, Gilead, GSK, iSpecimen, Janssen, Johnson and Johnson, Kowa, Merck, Necktar, Nichi-Iko, Novartis, NovoNordisk, Pfizer, Regeneron, Sanofi, Selecta, Takeda, and TIMI.
In the past 12 months, Dr. Harold Bays has served as a consultant/advisor for Alnylam, Akcea, Amgen, AstraZeneca, Eisai, Eli Lilly, Esperion, Ionis (ISIS), Janssen, Johnson and Johnson, Kowa, Merck, Novartis, Prosciento, Regeneron, and Sanofi
In the past 12 months, Dr. Harold Bays has served as a speaker for Amarin, Amgen, Eisai, Kowa, Orexigen, Regeneron, and Sanofi.
Kevin C. Maki, PhD – In the past 12 months, Dr. Kevin Maki has conducted Grant/Research for Amgen and Regeneron.
In the past 12 months, Dr. Kevin Maki has worked as a consultant and speaker for Amgen, AstraZeneca, and Kowa Pharmaceuticals America, Inc.
Joyce L. Ross, MSN, CRNP, CLS, FNLA, FPCNA – In the past 12 months, Joyce Ross has participated as a speaker for Amarin, Amgen, Sanofi, Regeneron, Kaneka America, and KOWA.
Catherine Davis Ahmed – No financial information to disclose.
The following contributors have no relevant financial relationships with commercial interests to disclose.
Global Education Group Planning Staff—Kristin Delisi, NP; Lindsay Borvansky; Ashley Marostica, RN, MSN; Andrea Funk; and Liddy Knight
Physicians' Education Resource®, LLC (PER®) The following contributors have no relevant financial relationships with commercial interests to disclose.
Continuing education activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
Required: Windows 7, Vista, XP, 2003 Server or 2000
Required: Mac OS X 10.4.11 (Tiger) or newer
For questions about this Internet CPE activity, please contact: email@example.com.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.